|
 |
Pharmaceutical Manufacturing and Packing Sourcer
|
Excipients are commonly defined as the additives used to convert pharmacologically active compounds into a pharmaceutical dosage form suitable for administering to patients. They are useful both as diluent of the active drug and processing aid for the formulation. Excipients should be physiologically inert and compatible with active ingredients. They should show no ageing in terms of physical and chemical stability and should be neutral in terms of odour, taste and colour. Many natural carbohydrates and their derivatives meet these requirements and therefore are widely used in the pharmaceutical industry.
Wet and dry granulation are frequently used methods for the manufacturing of tablets. But with the availability of specific developed excipients the pharmaceutical industry has the opportunity to choose a more efficient and economical process: direct compression. The choice of excipient is extremely critical in formulating direct compression tablets. Longstanding suppliers of pharmaceutical excipients, are therefore proactive in the research and development of new forms of excipient that are suitable for direct compression.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
7th Annual Pharma Packaging and Labelling conference
17 September - 18 October 2008, Barcelona
7th Annual Pharma Packaging and Labelling conference will bring
together experts from leading pharma manufacturers to present case study driven
presentations on critical industry-wide issues.
Attending this event will give you an opportunity to discuss with fellow
packaging and labelling professionals and share your views on these important
matters.
More info >> |
|
 |
News and Press Releases |
 |
Azopharma Announces Plans to Implement XcelodoseTM Technology in the Production of Early Stage Clinical Trial Materials
HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today plans to implement Xcelodose technology at its formulations development facility, ApiCross Drug Delivery Technologies. Xcelodose technology is a powder micro-dosing system developed by Meridica. This technology offers a unique powder dispensing system for small-scale capsule filling and ultimately assists in conserving valuable research material as well as reducing various Preformulation activities.
More info >> |
|
 |
